CTA
AMED

Carillon Tower Advisers’s Amedisys AMED Stock Holding History

Carillon Tower Advisers’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$96.7M Buy
329,800
+217,193
+193% +$55.7M 0.59% 41
2020
Q3 		$26.6M Sell
112,607
-276,142
-71% -$62.8M 0.36% 89
2020
Q2 		$77.2M Buy
388,749
+197,247
+103% +$36.8M 0.59% 43
2020
Q1 		$33.1M Hold
191,502
– – 0.32% 110
2019
Q4 		$32M Hold
191,502
– – 0.21% 166
2019
Q3 		$25.1M Hold
191,502
– – 0.17% 211
2019
Q2 		$23.3M Buy
+191,502
New +$22.7M 0.16% 227

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Carillon Tower Advisers's AMED Position: Q4 2020 in Review

Carillon Tower Advisers increased its Amedisys (AMED) stake by 193% in Q4 2020, buying an estimated $55.7M and bringing the position to 329,800 shares worth $96.7M. The position accounts for 0.59% of the portfolio, ranked #41.

Carillon Tower Advisers first reported a position in AMED in Q2 2019 and has held it in 7 quarters since. 398 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Carillon Tower Advisers held 329,800 shares of Amedisys worth $96.7M as of Q4 2020.
  • Carillon Tower Advisers bought 217,193 Amedisys shares in Q4 2020, an estimated $55.7M.
  • Amedisys made up 0.59% of Carillon Tower Advisers's portfolio in Q4 2020, its #41 holding.
  • Carillon Tower Advisers first reported a position in Amedisys in Q2 2019 and has held it in 7 quarters since.
  • 398 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.